Investment Summary |
|
|---|---|
| Date | 2013-01-01 |
| Target | York Commercial Park |
| Sector | Real Estate |
| Investor(s) | Actis Capital |
| Deal Type | Growth Capital |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2004 |
| PE ASSETS | 26.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Actis Capital is a private equity firm focused on investments in emerging markets. Actis segments its investment activity into three areas. These include private equity, energy, and real estate. Actis' private equity team looks for buyout and growth capital opportunities requiring at least $50 million in financing. Depending on the situation, Actis will consider both controlling and minority investment situations. Sectors of interest include financial services, consumer and retail, business services, and industrial. Actis' energy group seeks to invest in in a variety of energy and utility projects. Actis' real estate team invests equity capital in office, residential, industrial, hotel and retail projects. Actis Capital was established in 2004 and is based in London, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 101 of 163 |
| Sector: Real Estate M&A | 6 of 6 |
| Type: Growth Capital M&A Deals | 38 of 54 |
| Country: Zambia M&A | 1 of 1 |
| Year: 2013 M&A | 2 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-01-01 |
Beijing Chemclin Biotech Co.
Beijing, China Beijing Chemclin Biotech Co. Ltd. is a manufacturer of IVD products. In particular, it focuses on Chemiluminescence Immunoassay (CLIA) technology, which is gradually replacing other types of less advanced immunoassay IVD. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-01-09 |
Micro-Tech
Nanjing , China Micro-Tech is a manufacturer and seller of non-vascular stents and disposable biopsy forceps primarily in China, Europe, North America, and Oceania. Micro-Tech was founded in 1999 and is based in Nanjing, China. |
Buy | - |
